E11.3393. E11. E11.3393

 
E11E11.3393 If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P

3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. This is the American ICD-10-CM version of E11. 3412* Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. Myopic Choroidal Neovascularization (mCNV); or. 311, H44. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3411 Type 2 diabetes mellitus with severe non-proliferative diabetic retinopathy with macular edema, right eye; E11. 3392 became effective on October 1, 2023. The surgery involves excision of the lateral aspect of the stomach, leaving a much reduced, tubular stomach. 3541: proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3393* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 33 contain annotation back-referencesE11. 3391 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema right eye E11. 3412 E11. Denominator Criteria (Eligible Cases): Patients aged ≥ 18 years on date of encounterA disorder of the orbit, potentially affecting the visual field (e. Stationary infusion pump is an electrical device, which serves the same purpose as an ambulatory pump but. Under Associated Contractor Numbers added 11201, 11301, 11401, and 11501. 331,E11. 3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without. 3419 With severe non-proliferative retinopathy, without macular edema E11. Table: Dementia Exclusion Medications Description Prescription Cholinesterase inhibitors Donepezil Galantamine Rivastigimine Miscellaneous centralOCT, especially SCODI, produces high resolution, cross-sectional tomographic images of ocular structures and is used for the evaluation of the optic nerve head, nerve fiber layer, and retina. 2, or R11. 3312 E10. For the best performance and security, always keep your web browser up-to-date. . 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. moderate no e10. The required documentation listed below must be. Quality ID. 3313 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema E11. 117. 3519 E11. 3393 Type 2 diabetes mellitus with moderate. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3412 ☐. . Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy. 3412 Type 2 diabetes mellitus with severe non-proliferative diabetic retinopathy with macular edema, left. Shoe trauma, in concert with loss of protective sensation and concomitant foot deformity, is the leading eventScanning computerized ophthalmic diagnostic imaging (SCODI) allows for early detection of glaucomatous damage to the nerve fiber layer or optic nerve of the eye. All rights reserved. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. E11. E11. docx from Financial Management MISC at CDI College of Business, Technology and Health Care. . 82465. Treatment of infected foot wounds accounts for up to one-quarter of all inpatient hospital admissions for people withE11. Other Contractor Local Coverage Determinations. This revision has a retroactive effective date of 2/26/2018. 3411* Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. E11. Continuous Glucose Monitoring (CGM) Systems (also known as Real-Time or interstitial) monitor, measure, and record glucose levels in interstitial fluid and produce. 3122, h35. 3114, h35. 3412 e11. Search; Mission; Disclaimer; Acknowledgement; Contact UsProcedure during the performance period (CPT): 66840, 66850, 66852, 66920, 66930, 66940, 66982, 66983, 66984Coverage Indications, Limitations, and/or Medical Necessity. When performed laparoscopically, the term laparoscopic sleeve gastrectomy (LSG) is used. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 638, E13. , 2015). E11. The required documentation listed below must be. 3111, h35. Under Associated Contractor Numbers added 11201, 11301, 11401, and 11501. Scanning computerized ophthalmic diagnostic imaging (SCODI) allows for early detection of glaucomatous damage to the nerve fiber layer or optic nerve of the eye. It is used clinically to detect or monitor field loss due to disease at any of these locations. Denominator Exception: Documentation of patient reason(s) for not communicating the findings of the dilated macular or fundus exam to the physician or other qualified health care professional managing the ongoing care of theVersion 5. It is the goal of these diagnostic imaging tests to discriminate among patients with normal intraocular pressures (IOP) who have glaucoma, patients with elevated IOP who have. It is performed most commonly without anesthesia to: relieve pain, treat infection (bacterial, fungal, or viral), temporarily remove an anatomic deformity such as onychauxis (thickened nail), or certain types of onychocryptosis (ingrown nail), expose subungual conditions for the purpose of treatment as well as diagnosis (biopsy, culture,. mil. 3391 - E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3512. 3413 e11. 5. 3511. 339. Short description: Type 2 diab with mod nonp rtnop without macular edema, l eye The 2024 edition of ICD-10-CM E11. 9 and E11. 9 D34 D35. 3411 e11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. 321, E09. Original JH ICD-9 Source L32731, Frequency of Laboratory Tests. 3393: Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3392 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. All neoplasms, whether functionally. 3412 left eye E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3493 Key for Table 1: blue numerals (5th position) indicate whether nPdR is mild, moderate, or severe; green numerals (6th posi- This revision is due to the Annual ICD-10 Code Update and is effective on 10/1/20. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. Diabetes outpatient self-management and training service is a program which educates individuals in self-monitoring of blood glucose, diet, exercise, and insulin management. Description. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3311-E11. S. 3313 became effective on October 1, 2023. 37X3. 3522 e11. 3593 became effective on October 1, 2023. 10 - R11. E11. 01 Type 2 diabetes mellitus with hyperosmolarity with coma. A type 1 excludes note indicates that the code excluded should never be used at the same time as E11. E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. Continuous Glucose Monitoring (CGM) Systems (also known as Real-Time or interstitial) monitor, measure, and record glucose levels in interstitial fluid and produce data that show trends in glucose measurements. This measure. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. Diagnostic codes are the first step in the DRG mapping process. with . 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. Visual fields are examined using static or kinetic perimetry. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. The 2024 edition of ICD-10-CM E10 became effective on October 1, 2023. Symptoms concerning nutrition, metabolism and development. This measure. 3311 - E11. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. ICD-10 code E11. The supplier is responsible for ensuring that there is an appropriate. Performance Not Met: Most recent hemoglobin A1c (HbA1c) level < 7. This is the American ICD-10-CM version of E11. It means "not coded here". CMS Measure ID: #488 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical Care Measure Age: New Instructions. 3293 became effective on October 1, 2023. 3412 E10. This revision has a retroactive effective date of 2/26/2018. 341, E10. 81 C56. NUMERATOR OPTIONSPerformance Met: Most recent hemoglobin A1c level > 9. 3, F84. Quality ID #19 (NQF 0089): Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care – National Quality Strategy Domain: Communication and Care Coordination – Meaningful Measure Area: Transfer of Health Information and Interoperability 2019 COLLECTION TYPE: MEDICARE PART B CLAIMSQLLs Exceeded for test strips, lancets, lens shield cartridge. Diabetes outpatient self-management and training service is a program which educates individuals in self-monitoring of blood glucose, diet, exercise, and insulin management. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. E11. Quality ID #19 (NQF 0089): Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care – National Quality Strategy Domain: Communication and Care Coordination – Meaningful Measure Area: Transfer of Health Information and Interoperability 2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS)E11. 3124, h35. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. Percentage of cataract surgeries for patients aged 18 years and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following the cataract surgery. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. People with diabetes are at increased risk of serious health complications including vision loss, heart disease, stroke, kidney failure, amputation of toes, feet or legs, and premature death. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 311 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema. A portable external infusion pump may be considered medically necessary when ALL of the following are met: It is used for the administration of medications; and. QLLs that exceed the allowed amount of strips, lancet, and lens shield cartridges are covered when ALL of the following are met. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3392 e11. 3393 [convert to ICD-9-CM] Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral. They are not repeated. 10 - other international versions of ICD-10 E11. . E11. This measure is to be submitted a minimum of once per performance period for patients with diabetes seen during the performance period. Quality ID #1 (NQF 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) – National Quality Strategy Domain: Effective Clinical Care – Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION TYPE: MEDICARE PART B CLAIMS MEASURE TYPE:Description. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3491 e11. Initial authorization will be for a period of 12 months. 341, E10. 3511 e10. the measurement periodUnder Group 1: Codes added ICD-10 codes E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. E11. Type 2 diabetes mellitus with stable proliferative diabetic retinopathy. 3399 With severe nonproliferative retinopathy, with macular edema E11. 591, H18. 3411 ☐ E11. Instructions. Significance and UseThis practice is intended to provide a standard set of guidelines that are to be followed when conducting and reporting on inspections of. 1 VEGF is. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3313 bilateral E11. This article is being revised in order to adhere to CMS requirements per chapter 13, section 13. 37X9. 3412 E11. 3393 severe yes e10. This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association, 2018). 3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye. 3393 X E11. Chronic Kidney Disease (CKD) is a major driver of morbidity, mortality, and healthcare costs in the United States. E11. Ambulatory infusion pump is an electrical or battery operated device, which is used to deliver solutions containing a parenteral drug under pressure at a regulated flow rate. View E11. 2This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for Routine Foot Care. 41, E11. Continuous Glucose Monitoring (CGM) Systems (also known as Real-Time or interstitial) monitor, measure, and record glucose levels in interstitial fluid and produce. E11. This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of diabetes seen during the performance period. Percentage of cataract surgeries for patients aged 18 years and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following the cataract surgery. 3311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. Treatment of infected foot wounds accounts for up to one-quarter of all inpatient hospital admissions for people with 2023 MIPS Measure #127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear Pegcetacoplan injection (Syfovre) is a synthetic peptide that binds to complement protein C3 and its activation fragment C3b which then regulates the binding of C3 and the sequence of downstream effectors of the activated complement protein. E11. 3593, e11. The following services are considered to be components of routine foot care, regardless of the provider rendering the service: Cutting or removal of corns and calluses; Clipping, trimming, or debridement of nails, including debridement of mycotic nails; Shaving, paring, cutting or removal of keratoma, tyloma, and heloma;It is performed most commonly without anesthesia to: relieve pain, treat infection (bacterial, fungal, or viral), temporarily remove an anatomic deformity such as onychauxis (thickened nail), or certain types of onychocryptosis (ingrown nail), expose subungual conditions for the purpose of treatment as well as diagnosis (biopsy, culture,. Coverage Indications, Limitations, and/or Medical Necessity. Inability to. Find Tim Hortons in Sidney, with phone, website, address, opening hours and contact info. 3392 ☐ E11. 37X9, E11. All rights reserved. 9 D34 D35. Pay lesser of billed charges and cost invoice. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. 3492 e10. 3399 Type 2 diabetes mellitus with moderate nonpro. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. E11. 39 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with other diabetic ophthalmic complication. S. 3412 Methods. The surgery involves excision of the lateral aspect of the stomach, leaving a much reduced, tubular stomach. 3311 ☐E10. Measure Description. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3120, h35. 3 D09. The following ICD-10 code(s) have been added to Group 1 codes: G12. 81, E85. If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P. Summary of Evidence. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3393 became effective on October 1, 2023. E11. 22* Type 2 diabetes mellitus with diabetic chronic kidney disease. 20, H44. Short Description: Type 2 diab with mod nonp rtnop without macular edema, bi. Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam by an eye care professional during the measurement period or diabetics with no diagnosis of retinopathy in any part of the measurement period who had a retinal or. The equipment and supplies are prescribed by a physician; and The glucose monitor is covered; and The supplier of the test strips and lancets, or lens shield. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. E11. This will allow the postoperative period to occur within the reporting year. The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD. an estimated $327 billion: $237 billion in direct medical costs and $90 billion in reduced productivity. Payment may be made for only one pump for administering the medications; and. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 2019 MIPS Quality Measures for Claims Based Reporting or 2026F or 3072F * or G9714 7 standard field stereoscopic photos with interpretation (documented and reviewed)E11. e11. E11. Limited proprietary coding is contained in the measure specifications for convenience. Proliferative Diabetic Retinopathy Other) The following codes are effective beginning October 1, 2016. Coverage Indications, Limitations, and/or Medical Necessity. 3393: Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 00 or G70. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. E11. 3313 bilateral E11. 3499 e10. Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam by an eye care professional during the measurement period or diabetics with no diagnosis of retinopathy in any part of the. E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3393 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 3511. 3393 X E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3419 With severe nonproliferative retinopathy, without macular edema E11. 3542: left eye E11. 3133, h35. E11. 1 result found: ICD-10-CM Diagnosis Code E11. A distinct numeric result is required for numerator compliance. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3393 became effective on October 1, 2023. It is used clinically to detect or monitor field loss due to disease at any of these locations. This is the American ICD-10-CM version of E11. 3411 - E11. 3393 Type 2 diabetes mellitus with moderate non-proliferative diabetic retinopathy without macular edema, bilateral; E11. Measure Description. Refer to Billing and Coding: Bariatric Surgical Management of Morbid Obesity, A56422, for applicable CPT codes and diagnosis codes. No more than every two months for any test (e. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. In 2012, diabetes cost the U. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. E11. 3512 E11. Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam by an eye care professional during the measurement period or diabetics with no diagnosis of retinopathy in any part of the measurement period who had a retinal or. 10/10/2019. 3312 ☐ E11. It is the leading cause of blindness in adults between 20-74 years of age. Cataract development occurs in 60% of adults 65 years of age or greater. S. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. E11. 30, h35. CGM systems consist of a sensor, transmitter and receiver. E11. 3313 E10. 3591- E13. 3292 E11. November 2022 Page 3 of 11. Description. E13. 8 D27. E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. The sleeve gastrectomy (SG) is a surgical procedure performed in either an open or laparoscopic manner. This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012E11. 3313 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral. 3519 e10. 3411 Type 2 diabetes mellitus with severe nonproli. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality. Initial authorization will be for a period of 12 months. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 1The following services are considered to be components of routine foot care, regardless of the provider rendering the service: Cutting or removal of corns and calluses; Clipping, trimming, or debridement of nails, including debridement of mycotic nails; Shaving, paring, cutting or removal of keratoma, tyloma, and heloma;e10. Scanning computerized ophthalmic diagnostic imaging allows earlier detection of glaucoma and more sophisticated analysis for ongoing management. 2019 Clinical Quality Measure Flow Narrative for Quality ID #126 NQF #0417: Diabetes Mellitus: Diabetic Foot and Ankle Care Peripheral Neuropathy – Neurological Evaluation Please refer to the specific section of the specification to identify the denominator and numerator information for useICD10 CPT codes 84436 84439 84443 and or 84479 Thyroid Testing Code A18. 3393* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema right eye E11. 3393 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. E11. 3311 became effective on October 1, 2023. The goal of this Local Coverage Determination (LCD) is to ensure that evidence-based medicine addressing the risks of acute and chronic complications of diabetes mellitus (DM) are integrated into the delivery of home health (HH) services for Medicare beneficiaries with Type II DM. When performed laparoscopically, the term laparoscopic sleeve gastrectomy (LSG) is used. 319,Quality ID #119 (NQF 0062): Diabetes: Medical Attention for. 33. 3393, look in the list below to see which MDC's "Assignment of Diagnosis Codes" is first. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3511 e11. 3411 e11. E11. 1 of the Program Integrity Manual, to remove all coding from LCDs and incorporate into related Billing and Coding Articles. Diabetic retinopathy is progressive damage to the small blood vessels in the retina that may result in loss of vision. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3313 became effective on October 1, 2023. Electroretinography used to diagnose loss of retinal function or distinguish between retinal lesions and optic nerve lesions may be considered medically necessary for ANY ONE of the following indications (This is not an all-inclusive list):. 3399 With severe nonproliferative retinopathy, with macular edema E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. This measure may be submitted by non-medical doctor/doctor of osteopathic medicine (MD/DO) Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. Measure #118 (NQF 0066): Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). Revisions Due. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. E13. Cataract development occurs in 60% of adults 65 years of age or greater. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. an estimated $327 billion: $237 billion in direct medical costs and $90 billion in reduced productivity. Palliative care services provided to patient any time during the measurement period. 3311 E11. 3391-E11. 3412 left eye E11. ).